ArticleNature communications2022
Causal deep learning reveals the comparative effectiveness of antihyperglycemic treatments in poorly controlled diabetes.
Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A machine learning model for optimizing treatment of patients with poorly controlled type 2 diabetes.Communications medicine · 2026Article
- Exploring the therapeutic effects of continuous kidney replacement therapy in patients with severe acidosis using deep learning-based causal inference.Scientific reports · 2025Article
- CRISP: A causal relationships-guided deep learning framework for advanced ICU mortality prediction.BMC medical informatics and decision making · 2025Article
- Applying AI to Structured Real-World Data for Pharmacovigilance Purposes: Scoping Review.Journal of medical Internet research · 2024Article
- Harnessing EHR data for health research.Nature medicine · 2024Review
- Opportunistic detection of type 2 diabetes using deep learning from frontal chest radiographs.Nature communications · 2023Article
- Analysis of age-dependent gene-expression in human tissues for studying diabetes comorbidities.Scientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type-2 diabetes is associated with severe health outcomes, the effects of which are responsible for approximately 1/4
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.